Podcast: Play in new window
Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. His research focuses on unlocking the therapeutic potential of macrophages for the benefit of cancer patients. He talks about the role of macrophages in the tumor environment and how targeting the CD47/SIRPα axis can induce phagocytosis of cancer cells. He also discusses starting spin-off companies to advance cancer therapies.
Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate…
Dr. Roslyn Kemp is a Professor of Immunology at the University of Otago. Dr. Kemp’s research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically, they study…
Podcast: Play in new window
Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California, San Francisco. His lab studies how the developmental properties of a tissue influence its ability to mount a successful immune response. He talks about immune tolerance in pregnancy and how the maternal–fetal interface affects pregnancy outcomes.
Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California San Francisco. His research lies at the intersection of immunology and developmental biology….
